Absci Investor Presentation Deck

NON-STANDARD AMINO ACID INCORPORATION Unlocking new molecular functionalities and application Bionic SoluPro™ platform enables site-specific non-standard amino acid incorporation into difficult-to-produce biologics ● • designed for maximum incorporation efficiency ● Unlocks functionalities such as chemical modification, drug conjugation, pegylation, glycosylation ABSCI CORPORATION 2023 ALL RIGHTS RESERVED Use in wide range of applications • development of ADCs with improved therapeutic properties (pharmacokinetic, efficacy, and safety profiles) half-life extension ● • site-specific, homogeneous, designer glycosylation attachment of novel chemical moieties enzyme immobilization/modification ● absci. 36

View entire presentation